Addictive disorders in adolescents

被引：24

作者：

Kaminer, Y ^{[1
]}

机构：

[1] Univ Connecticut, Ctr Hlth, Dept Psychiat, Alcohol Res Ctr, Farmington, CT 06030 USA

来源：

PSYCHIATRIC CLINICS OF NORTH AMERICA | 1999年 / 22卷 / 02期

关键词：

D O I：

10.1016/S0193-953X(05)70076-9

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

Substance use and abuse among adolescents in the United States is highly prevalent and continues to be a serious problem. Compared to the literature available for adult treatment, relatively little empirical data has been directed at developing effective treatment for adolescents. This article reviews the following topics: epidemiology of substance abuse in adolescents, the natural history of adolescent substance use, and the transition to substance use disorders (SUD), psychiatric comorbidity, assessment, prevention, and treatment.

引用

页码：275 / +

页数：15

共 37 条

[1]

[Anonymous], 1989, PERSONAL EXPERIENCE

[2]

[Anonymous], 1993, The American Journal on Addictions

[3] YOUTH DRUG-ABUSE TREATMENT - A CONTROLLED OUTCOME STUDY [J].

AZRIN, NH ;

DONOHUE, B ;

BESALEL, VA ;

KOGAN, ES ;

ACIERNO, R .

JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE, 1994, 3 (03) :1-16

[4]

BATES ME, 1997, ALCOHOL CLIN EXP RES, V38, P426

[5] LONG-TERM FOLLOW-UP RESULTS OF A RANDOMIZED DRUG-ABUSE PREVENTION TRIAL IN A WHITE MIDDLE-CLASS POPULATION [J].

BOTVIN, GJ ;

BAKER, E ;

DUSENBURY, L ;

BOTVIN, EM ;

DIAZ, T .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (14) :1106-1112

[6]

Brown S. A., 1994, APPLIED PREVENTIVE P, V3, P61, DOI [10.1016/S0962-1849(05)80139-8, DOI 10.1016/S0962-1849(05)80139-8]

[7]

BUKSTEIN OG, 1989, AM J PSYCHIAT, V146, P1131

[8] EVALUATION OF THE EFFECTIVENESS OF ADOLESCENT DRUG-ABUSE TREATMENT, ASSESSMENT OF RISKS FOR RELAPSE, AND PROMISING APPROACHES FOR RELAPSE PREVENTION [J].

CATALANO, RF ;

HAWKINS, JD ;

WELLS, EA ;

MILLER, J ;

BREWER, D .

INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1991, 25 (9A-10A) :1085-1140

[9]

CLARK DB, 1995, PSYCHIATR SERV, V46, P618

[10]

CLAYTON RR, 1992, VULNERABILITY DRUG A

← 1 2 3 4 →